Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial. 

Dalziel, S.R., Borland, M.L., Furyk, J., Bonisch, M., Neutze, J., Donath, S., Francis, K.L., Sharpe, C., Harvey, A.S., Davidson, A., Craig, S., Phillips, N., George, S., Rao, R., Cheng, N., Zhang, M., Kochar, A., Brabyn, C., and Babl, F. 2019. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial. The Lancet, 393(10186), pp.2135-2145.